Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.12B 899M 788M 728M 673M 1.27B 86.07B 1.3B 8.75B 3.4B 42.12B 3.38B 3.3B 146B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 6.99B 1.03B 901M 832M 769M 1.46B 98.38B 1.49B 10B 3.89B 48.14B 3.86B 3.77B 167B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day+0.90%
1 week+2.99%
Current month+3.23%
1 month+0.90%
3 months-11.46%
6 months+4.43%
Current year+2.99%
1 week 4.4
Extreme 4.4
4.74
1 month 4.21
Extreme 4.21
4.91
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.94
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Director/Board Member 58 25/12/2007
Chairman 56 27/03/2026
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap.
21/09/20Sell

Chairman

1,940,600 0.2495%
18/09/20Sell

Director

3,670,000 0.4719%
18/09/20Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%+2.99%-18.55%-48.56% 899M
+0.04%+1.46%-13.03%-6.44% 12.76B
+1.34%+0.65%-34.33%-56.33% 4.72B
+0.15%+2.06%-8.54%-4.43% 4.41B
+1.14%+4.30%+22.79%-2.44% 3.89B
+0.52%+0.20%+4.48%-38.18% 3.78B
+3.03%+5.92%-8.04%-13.49% 3.22B
+0.21%+3.38%-11.41%+2.48% 3.09B
+3.96%+4.58%-4.78%-21.76% 2.44B
+2.10%+9.66%-5.56%+44.84% 1.81B
Average +1.34%+1.90%-7.70%-14.43% 4.1B
Weighted average by Cap. +0.94%+1.26%-8.77%-13.96%

Financials

2024 2025
Net sales 3.83B 562M 493M 455M 421M 797M 53.84B 813M 5.47B 2.13B 26.35B 2.11B 2.07B 91.46B 3.05B 448M 393M 363M 335M 636M 42.91B 648M 4.36B 1.69B 21B 1.68B 1.65B 72.89B
Net income 33.62M 4.94M 4.33M 4M 3.7M 7.01M 473M 7.15M 48.11M 18.69M 232M 18.56M 18.15M 804M -104M -15.34M -13.45M -12.42M -11.48M -21.76M -1.47B -22.19M -149M -58.02M -719M -57.61M -56.34M -2.5B
Net Debt 1.4B 206M 181M 167M 154M 292M 19.71B 298M 2B 779M 9.64B 773M 756M 33.48B 875M 129M 113M 104M 96.2M 182M 12.31B 186M 1.25B 486M 6.02B 483M 472M 20.91B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
08/07/26 CN¥4.480 +0.90% 5,599,400
07/07/26 CN¥4.440 -2.84% 7,132,200
06/07/26 CN¥4.570 -0.22% 12,114,522
03/07/26 CN¥4.580 +1.10% 13,319,700
02/07/26 CN¥4.530 +4.14% 16,288,234

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock